Sharp Daily
No Result
View All Result
Thursday, July 10, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home News

Pharmacy board clears Mefenamic Acid suspension for market distribution

Huldah Matara by Huldah Matara
March 18, 2025
in News
Reading Time: 1 min read

The Pharmacy and Poisons Board (PPB) of Kenya has officially lifted the quarantine order placed on Mefnac Oral Suspension (Mefenamic Acid 50 mg/5 ml), manufactured by Efroze Chemical Industries Pvt Ltd, Pakistan. The decision follows extensive quality control assessments and safety investigations.

The initial quarantine order was issued on December 11, 2024, as a precautionary measure to evaluate potential health risks. However, after thorough testing, the regulatory body confirmed that the product meets all required safety standards.

“The results confirm that the product meets all applicable specifications and is safe for distribution and use,” stated the PPB in an official release.

A key factor in the investigation was testing for the presence of harmful contaminants such as Diethylene Glycol (DEG) and Ethylene Glycol (EG), which have been linked to serious health risks in other pharmaceutical incidents worldwide. The clearance by PPB assures the public that Mefnac Oral Suspension adheres to regulatory guidelines and can now be distributed without restrictions.

RELATEDPOSTS

Pharmacy and poisons board issues advisory on safe handling of health products

March 12, 2025

Pharmacy practitioners face suspensions over violations of professional standards

January 16, 2025

Despite lifting the quarantine, the board has emphasized continued vigilance in monitoring pharmaceutical products. “The Board urges the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or through our official reporting channels,” the statement read.

The PPB provided multiple avenues for the public to report concerns, including an online platform, a USSD code (*271#), the mPvERS mobile application, and direct contact via email or telephone.

The regulator reaffirmed its commitment to public health and safety, stating that it will maintain strict oversight to ensure all medications in the Kenyan market meet the highest quality and safety standards.

The lifting of the quarantine is expected to ease supply concerns for Mefnac Oral Suspension, a commonly used nonsteroidal anti-inflammatory drug (NSAID), particularly for pain relief and inflammation management.

Previous Post

What is a money market fund? – understanding how CMMF works

Next Post

Kenya Meteorological department confirms onset of March-April-May rainy season

Huldah Matara

Huldah Matara

Versatile multimedia journalist with a keen interest in compelling stories that resonate with my audience. Reach out on huldahmatara12@gmail.com

Related Posts

Business

Del Monte foods files for bankruptcy in USA

July 3, 2025
News

Private vs Public Pension Funds in Kenya

June 30, 2025
Investments

Investor shift to long term bonds drives oversubscription in CBK’s reopened auction

June 19, 2025
News

The real price of Israel – Iran Conflict for Kenya.

June 19, 2025
Economy

Resilient but strained: Kenyan firms speak out in May 2025 CEO survey.

June 19, 2025
News

Co-op Bank posts KES 6.9 billion profit in Q1’2025

May 16, 2025

LATEST STORIES

Why Employers Should Prioritize Pensions Over One-Time Gratuity Payments

July 10, 2025
Business and Finance Concept - Coin, Currency, Financial Item, Graph,

Opinion: Why lower taxes may be Kenya’s only escape route

July 10, 2025

Nvidia becomes the first company globally to hit USD 4.0 trillion market value

July 10, 2025

Privatization in Kenya: A new dawn for capital markets and fiscal stability

July 10, 2025

How Kenya is future-proofing its economy against illicit finance

July 9, 2025

The importance of Investment Policy Statements (IPS) for pension schemes in Kenya

July 4, 2025

Understanding Life Cover as an Additional Benefit in Retirement Benefit Schemes

July 4, 2025

Del Monte foods files for bankruptcy in USA

July 3, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024